LINK Embrace Shoulder System Line Extension
FDA UDIEUDAMEDClass II (US FDA UDI)
Identity
- Trade Name
- LINK Embrace Shoulder System Line Extension FDA UDILINK Embrace Shoulder System FDA UDI
- Generic Name
- Orthopaedic bone screw (non-sliding) FDA UDIPolyethylene reverse shoulder prosthesis cup FDA UDI
- Device Name
- LINK Embrace Shoulder System EUDAMEDBone Screws, and Cortical Bone Screw FDA UDIReverse Inserts, neutral, cPE FDA UDI
- Model / Reference
- 643-039/00 EUDAMEDFDA UDIGlenoid insert, uncemented, UHMWPE, reverse EUDAMED645-076/25 FDA UDI
- Description
- Bone Screws, and Cortical Bone Screw FDA UDIReverse Inserts, neutral, cPE FDA UDI
Identifiers
- Catalog Number
- 645-076/25 FDA UDI643-039/00 FDA UDI
- Primary DI / UDI-DI
- 04026575237234 EUDAMEDFDA UDI04026575533596 FDA UDI
- Basic UDI-DI
- 4026575-1-OEX-300015-WK EUDAMED
- FDA Product Code
- PAO FDA UDIPHX FDA UDIHSD FDA UDI
- EMDN Code
- P090104010201 EPIPHYSARY HUMERAL COMPONENTS FOR REVERSE PROSTHESES - INSERTS EUDAMED
- GMDN Term
- Orthopaedic bone screw (non-sliding) FDA UDIPolyethylene reverse shoulder prosthesis cup FDA UDI
Classification
- Device Class
- Class III EUDAMEDClass II FDA UDI
- Regulation Number
- 888.3660 FDA UDI888.3690 FDA UDI
- Market of Registration
- Germany EUDAMED
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
Single Use
No
Implantable
Yes
Reusable
No
Contains Latex
No
Reprocessed
No
CMR Substance
No
Human-derived
No
Human Tissues
No
Animal Tissues
No
Endocrine Disruptor
No
Administering Medicine
No
Measuring Function
No
Incorporates Medicinal Product
No
Prescription Use
Yes
Over-the-Counter
No
Convenience Kit
No
Combination Product
No
HCT/P
No
Premarket Exempt
No
Lot / Batch Number
Yes
Serial Number
No
Expiration Date
Yes
Manufacturing Date
No
Category: Orthopaedic bone screw (non-sliding)
LINK Embrace Shoulder System Line Extension by WALDEMAR LINK GmbH & Co. KG — Class II — MDR, FDA UDI — listed in FDA GUDID, EUDAMED
Similar devices
Also classified as Orthopaedic bone screw (non-sliding).
- EVOS — Smith & Nephew, Inc. · Class II
- TriLeap Lower Extremity Anatomic Plating System — CROSSROADS EXTREMITY SYSTEMS LLC · Class II
- Arthrex® — Arthrex, Inc. · Class II
- Zavation — ZAVATION · Class II
- STARDRIVE — Synthes GmbH · Class IIb
- Arthrex® — Arthrex, Inc. · Class II
- Cancellous Screw, Locking — I.T.S. GmbH · Class II
- PANGEA — Stryker Corp. · Class II
Cleared under the same submission
K231445 also covers:
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
- LINK Embrace Shoulder System Line Extension — WALDEMAR LINK GmbH & Co. KG
Authorization Coverage (2 countries)
Regulatory Authorizations
MDR
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | MDR | — | Class II | Unknown |
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- WALDEMAR LINK GmbH & Co. KG
Sources (3)
- FDA UDI 264d37de-e8d8-4d4a-8279-d3a2dae355fe 35 fields · synced Sep 17, 2026
- FDA UDI 2f05d248-bc8c-4746-93dc-f9757984aea6 35 fields · synced May 29, 2026
- EUDAMED 928b5292-dea2-4148-b1fc-e8bfe4d6cc3b 61 fields · synced Sep 17, 2026